1.52BMarket Cap-659P/E (TTM)
31.545High29.810Low184.12KVolume31.050Open31.470Pre Close5.59MTurnover0.44%Turnover RatioLossP/E (Static)50.78MShares47.97052wk High-46.56P/B1.25BFloat Cap8.43052wk Low--Dividend TTM41.72MShs Float318.750Historical High--Div YieldTTM5.51%Amplitude2.650Historical Low30.355Avg Price1Lot Size
Spyre Therapeutics Stock Forum
U.S. stocks advanced on Monday, building off a record finish ahead of the ramping up of fourth-quarter earnings season.
The $Dow Jones Industrial Average(.DJI.US)$ rose 138 points, or 0.26%, to 38,000. The $S&P 500 Index(.SPX.US)$ was up 10 points, or 0.22%, at 4,850. The $Nasdaq Composite Index(.IXIC.US)$advanced 49 points, or 0.32%, to 15,360.
While the S&P 500 finally returned to record territory on Friday, skeptic...
Spyre felt the positive pressure from fresh buy ratings by analysts like Stifel. $Ginkgo Bioworks(DNA.US)$ also roase 9%, despite a new sell rating from Goldman Sachs.
But monday morning was not al...
No comment yet